Children's Cancer Institute Australia

Promising new therapy developed to treat leukaemia

12 December 2019 | By Hannah Balfour (Drug Target Review)

VTP50469, a new targeted therapy for MLL-rearranged leukaemia, shows greater efficacy and fewer side-effects in mice, according to new research.